Furthermore, using a patient-derived xenograft (PDX) model of cytarabine resistance, it was shown that the transcriptome of residual AML cells that were resistant to cytarabine treatment in vivo was highly enriched in genes involved in inflammatory and immune response, including the NF-kB network (71, 90). The gene discussed is NFKB1; the disease is acute myeloid leukemia.